IntervaOpen the desk

World Bank · Health

Cameroon: Antiretroviral therapy coverage for PMTCT

59percent · 2024-32.2% since 2014

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT). Annual figures for Cameroon from 2000 to 2024.

20002024

Every year

YearValue (percent)Note
202459
202372
202279
202183
202077
201977
201895
201797
201694
201591
201487
201388
201265
201155
201047
200930
200833
200724
200624
200511
200413
20038
20024
20010
20000

Source

Published by World Bank, produced by UNAIDS. Licence: CC BY 4.0. Retrieved 2026-11-08.

The dataset for every country, with quality and provenance →

Cite or download

World Bank (2026). Antiretroviral therapy coverage for PMTCT. Interva. https://interva.co/dataset/worldbank-antiretroviral-therapy-coverage-for-pmtct (accessed 2026-11-15). catalog snapshot 2026-11-08.

JSON, CameroonAPI and MCP

Antiretroviral therapy coverage for PMTCT in other countries

Rank Cameroon against its region, see where publishers disagree, or ask a question in plain words on the Interva desk.

Cameroon: Antiretroviral therapy coverage for PMTCT (2000–2024) · Interva